stars 1 stars 2 stars 3

Vectorious Medical Technologies develops novel treatment for heart failure patients which is based on physician directed, patients’ self-management paradigm. Leveraging its advanced, first of its kind, implantable V-LAP platform, which harvests valuable information from the heart’s left atrium, physicians and patients can monitor and manage disease status, prevent hospitalizations and improve quality of life. The V-LAP system is an investigational device which is currently under evaluation in multiple clinical studies in Europe, Israel and the U.S.

Vectorious Medical Technologies Questions

The Vectorious Medical Technologies annual revenue was $6 million in 2026.

Eyal Orion is the Co-Founder, CEO of Vectorious Medical Technologies.

97 people are employed at Vectorious Medical Technologies.

The NAICS codes for Vectorious Medical Technologies are [334, 33].

The SIC codes for Vectorious Medical Technologies are [38, 384].

Top Vectorious Medical Technologies Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users